Idiopathic Generalized Epilepsy: Misunderstandings, Challenges, and Opportunities

Area of Science:

• Neurology
• Epileptology
• Clinical Neuroscience

Background:

• Idiopathic generalized epilepsies (IGE) represent 20% of all epilepsy cases but receive less than 1% of research funding.
• Common misperceptions suggest IGE is easily diagnosed, understood, treated, outgrown, and has low morbidity, which is increasingly being challenged by emerging evidence.

Purpose of the Study:

• To highlight the significant underrepresentation of IGE in epilepsy research.
• To challenge prevailing misperceptions regarding the diagnosis, pathophysiology, and clinical course of IGE.
• To underscore the need for improved diagnostic accuracy, scientific understanding, and therapeutic interventions for IGE.

Main Methods:

• Review of emerging evidence from genetic, electrophysiologic, and neuroimaging studies.
• Analysis of diagnostic challenges, including misdiagnosis with focal epilepsy.
• Examination of clinical characteristics such as adult onset, drug resistance, and comorbidities.

Main Results:

• Patients with IGE are frequently misdiagnosed, particularly when exhibiting focal or asymmetric features on EEG or semiology.
• IGE can present in adulthood and is often associated with chronic, drug-resistant seizures.
• Comorbidity rates, including psychiatric issues and sudden unexpected death in epilepsy (SUDEP), are comparable to focal epilepsies.

Conclusions:

• IGE is an understudied epilepsy spectrum with inadequate diagnostic tools, scientific understanding, and treatment options.
• Addressing the research gap in IGE is crucial for improving patient outcomes and reducing the burden of epilepsy.
• Further research into the pathophysiology and novel therapies, including neuromodulation, is warranted for drug-resistant IGE.